What is BLLN's Value Score?

BillionToOne, Inc. - Class A common stock (BLLN) has a StockPik Value Score of 76 out of 100 — a high score, indicating strong value characteristics across multiple metrics. The Value Score is a composite ranking built from P/E ratio, P/B ratio, Graham Number, ROE, gross margin, debt-to-equity, current ratio, and Piotroski F-Score, calculated from SEC EDGAR annual filing data.

What is BLLN's Piotroski F-Score?

BillionToOne, Inc. - Class A common stock (BLLN) has a Piotroski F-Score of 7 out of 9 — a strong score indicating the company is financially improving across most criteria. The F-Score assesses nine binary financial criteria across profitability, leverage, and operating efficiency. A score of 7–9 indicates a financially improving company; a score of 0–3 is a warning sign.

Is BLLN trading below its Graham Number?

BLLN is currently trading above its Graham Number. The stock price of $77.49 exceeds the Graham Number of $17.87, meaning it does not meet Graham's criterion for a margin of safety at the current price. The Graham Number is calculated as √(22.5 × EPS × Book Value Per Share) and represents Benjamin Graham's ceiling price for a defensive investor.

What is BLLN's Graham Number?

BLLN's Graham Number is $17.87, calculated using the Benjamin Graham formula √(22.5 × EPS × Book Value per Share). The Graham Number is an estimate of intrinsic value — the maximum price a defensive investor should pay. At the current price of $77.49, BLLN is trading 334% above its Graham Number.

What is BLLN's Piotroski F-Score?

BLLN's Piotroski F-Score is 7 out of 9, indicating strong financial health and improving fundamentals. The Piotroski F-Score evaluates nine criteria across profitability, leverage, and operating efficiency. Scores of 7 or above are considered strong; 3 or below indicate financial weakness.

Is BLLN (BillionToOne, Inc. - Class A common stock) undervalued?

BLLN scores 76/100 on StockPik's Value Score, placing it in undervalued territory. The stock trades 334% above its Graham Number of $17.87.

What is BLLN's P/E ratio?

BLLN's trailing P/E ratio is 165.0x — an elevated earnings multiple, potentially pricing in high growth expectations. The Healthcare sector average P/E is 25.2x. Compare against other Healthcare stocks in the StockPik screener.

What sector is BillionToOne, Inc. - Class A common stock (BLLN) in?

BillionToOne, Inc. - Class A common stock (BLLN) is in the Healthcare sector, specifically in the Services-Medical Laboratories industry. Compare it against other Healthcare stocks by Value Score, P/E ratio, and Piotroski F-Score on StockPik.

Back to Screener

BillionToOne, Inc. - Class A common stock (BLLN)

NASDAQ Small Cap

Healthcare › Services-Medical Laboratories

$77.49

Market Cap: $1.2B

Data as of Dec 31, 2025

Price History

Feb 9, 2026 — May 4, 2026

Investment Snapshot

Trading 334% above Graham Number — above intrinsic value estimate
Piotroski F-Score 7/9 — financially strong with improving fundamentals
ROE of 1.6% — below-average profitability
Revenue growing at 100% annually

BillionToOne, Inc. - Class A common stock (BLLN) is a Healthcare company operating in Services-Medical Laboratories, listed on the NASDAQ , with a market capitalisation of $1.2 billion . Key value metrics: P/E ratio 165.0, P/B ratio 2.56, Piotroski F-Score 7 out of 9 (strong financial health) .

Value Score

out of 100

Try PRO Free — See Full Breakdown

Key Metrics

P/E Ratio

165.03

P/B Ratio

2.56

EPS

$0.47

Div. Yield

—

PEG Ratio

—

P/S Ratio

—

EV/EBITDA

—

ROE

—

ROA

—

Gross Margin

—

Op. Margin

—

Net Margin

—

Debt/Equity

—

Current Ratio

—

Unlock 19 More Metrics — 7 Days Free

Financial Statements

Metric	FY22	FY23	FY24
Revenue	$X.XB	$X.XB	$X.XB
Gross Profit	$X.XB	$X.XB	$X.XB
Operating Income	$X.XB	$X.XB	$X.XB
Net Income	$X.XB	$X.XB	$X.XB
EBITDA	$X.XB	$X.XB	$X.XB
Total Assets	$X.XB	$X.XB	$X.XB
Total Liabilities	$X.XB	$X.XB	$X.XB

Unlock 5 Years of Financials — Start Free Trial

Data sourced from SEC EDGAR and Polygon.io. Methodology. View more Healthcare stocks →

BillionToOne, Inc. - Class A common stock — Fundamental Analysis Summary

BillionToOne, Inc. - Class A common stock (BLLN) is currently trading 334% above its Graham Number of $17.87, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 165.0x.

On financial health, BLLN shows a strong Piotroski F-Score of 7/9, indicating improving fundamentals across profitability, leverage, and efficiency, and modest return on equity of 1.6% (sector average: -20.6%), and minimal leverage with a debt-to-equity ratio of 0.12.

StockPik's composite Value Score for BLLN is 76/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.

BLLN reports a high gross margin of 68.3% (sector average: 40.1%) and a modest operating margin of 5.3%.

BLLN shows revenue growing at 100% year-over-year, with earnings growing at 118%.

Top Value Stocks in Healthcare

Symbol	Name	Price	P/E	Score
EMBC	Embecta Corp. - Common Stock	$3.90	2.1	100
HCM	HUTCHMED (China) Limited - American Depositary Shares	$13.31	5.1	100
GMAB	Genmab A/S - American Depositary Shares	$27.06	1.8	100
CGEN	Compugen Ltd. - Ordinary Shares	$2.71	7.3	100
INVA	Innoviva, Inc. - Common Stock	$22.89	5.8	100

Browse all Healthcare value stocks →

High Piotroski F-Score stocks

Other stocks with F-Score ≥ 7 showing broad financial improvement

How is the Value Score calculated?

Read our full methodology →

How is the Graham Number calculated?

Benjamin Graham's intrinsic value formula, worked examples, and how to use it →

BLKB — Blackbaud, Inc. - Common Stock

Bloomin' Brands, Inc. - Common Stock — BLMN